BioRestorative Therapies, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BioRestorative Therapies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • BioRestorative Therapies, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.29M, a 26.3% increase year-over-year.
  • BioRestorative Therapies, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$12.1M, a 27.6% increase year-over-year.
  • BioRestorative Therapies, Inc. annual Operating Income (Loss) for 2023 was -$15.2M, a 19.8% increase from 2022.
  • BioRestorative Therapies, Inc. annual Operating Income (Loss) for 2022 was -$19M, a 27.9% increase from 2021.
  • BioRestorative Therapies, Inc. annual Operating Income (Loss) for 2021 was -$26.3M, a 856% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$12.1M -$2.29M +$817K +26.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$12.9M -$2.47M +$648K +20.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$13.6M -$4.11M +$1.67M +28.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-06-11
Q4 2023 -$15.2M -$3.22M +$1.46M +31.2% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-06-11
Q3 2023 -$16.7M -$3.1M +$1.51M +32.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$18.2M -$3.12M +$1.51M +32.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$19.7M -$5.78M -$725K -14.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-06-11
Q4 2022 -$19M -$4.68M -$673K -16.8% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-06-11
Q3 2022 -$18.3M -$4.61M -$921K -25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$17.4M -$4.63M -$1.07M -30.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$16.3M -$5.05M +$10M +66.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$26.3M -$4.01M -$3.15M -366% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$23.2M -$3.69M -$3.08M -504% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$20.1M -$3.56M -$3.09M -670% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$17M -$15.1M -$14.2M -1738% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$2.75M -$861K +$1.29M +60.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$4.05M -$610K +$1.21M +66.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$5.26M -$462K +$1.67M +78.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$6.92M -$819K +$1.51M +64.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$8.43M -$2.16M +$22K +1.01% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-30
Q3 2019 -$8.45M -$1.82M -$630K -53% Jul 1, 2019 Sep 30, 2019 10-Q 2021-04-12
Q2 2019 -$7.82M -$2.13M -$78.5K -3.83% Apr 1, 2019 Jun 30, 2019 10-Q 2021-04-12
Q1 2019 -$7.75M -$2.33M -$97.6K -4.38% Jan 1, 2019 Mar 31, 2019 10-Q 2021-03-29
Q4 2018 -$7.65M -$2.18M -$606K -38.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 -$7.04M -$1.19M +$555K +31.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$7.6M -$2.05M +$519K +20.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$8.12M -$2.23M +$259K +10.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$8.37M -$1.57M +$287K +15.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$8.66M -$1.74M -$28.4K -1.66% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$8.63M -$2.57M -$426K -19.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$8.21M -$2.49M -$422K -20.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$7.79M -$1.86M +$932K +33.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$8.72M -$1.72M -$225K -15.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$8.49M -$2.14M -$880K -69.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$7.61M -$2.07M -$441K -27.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$7.17M -$2.79M -$1.48M -112% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$5.7M -$1.49M -$594K -66.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 -$5.1M -$1.26M +$18.7K +1.46% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$5.12M -$1.63M -$198K -13.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$4.92M -$1.32M -$107K -8.83% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$4.82M -$896K +$233K +20.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 -$5.05M -$1.28M -$168K -15% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$4.88M -$1.43M -$129K -9.91% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$4.75M -$1.21M +$494K +29% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$5.25M -$1.13M +$76.2K +6.32% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$5.32M -$1.11M +$225K +16.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$5.55M -$1.3M +$24.6K +1.86% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$5.57M -$1.7M -$1.06M -165% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-11
Q3 2012 -$4.51M -$1.21M -$352K -41.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-19
Q2 2012 -$4.16M -$1.34M -$301K -29% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-19
Q1 2012 -$3.86M -$1.32M -$307K -30.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$3.55M -$643K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-02
Q3 2011 -$853K -$483K -130% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 -$1.04M -$860K -481% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.02M Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-06-01
Q3 2010 -$370K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$179K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.